hybritech, shatterproof

custom search

REVERSED
Tech Center 1600 Biotechnology and Organic Chemistry
1619 Ex Parte ALBRECHT 14845651 - (D) ADAMS 103 GlaxoSmithKline CHICKOS, SARAH J

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2411 Ex Parte Larsson et al 13202670 - (D) BAUMEISTER 103 BAKER BOTTS L.L.P. ANDREWS, HOYET H

2485 Ex Parte Chapman et al 14136104 - (D) SHAW 103 Steven C. Tietsworth TORRENTE, RICHARDT

Tech Center 2600 Communications
2648 Ex Parte LI et al 14499002 - (D) SHAW 103 DICKINSON WRIGHT RLLP SHIUE, DONG-CHANG

Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2886 Ex Parte Kirchner et al 14366589 - (D) OWENS 103 MCDONNELL BOEHNEN HULBERT & BERGH OFF LLP/ AkzoNobel AHMED, JAMIL

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3693 Ex Parte Lavoie et al 12635568 - (D) SHAH 101 41.50 112(2) KHATTAR, RAJESH KHATTAR, RAJESH

Claims are in compliance with 35 U.S.C. § 112(b)/second paragraph if "the claims, read in light of the specification, reasonably apprise those skilled in the art both of the utilization and scope of the invention, and if the language is as precise as the subject matter permits." Hybritech Inc. v. Monoclonal Antibodies, Inc., 802 F.2d 1367, 1385 (Fed. Cir. 1986) (citing Shatterproof Glass Corp. v. Libbey Owens Ford Co., 758 F.2d 613, 624 (Fed. Cir. 1985)). 

Hybritech, Inc. v. Monoclonal Antibodies, Inc., 802 F.2d 1367, 231 USPQ 81 (Fed. Cir. 1986)   716.03(b) ,   2138.04 ,   2145 ,   2163 ,   2164.01 ,   2164.05(a) ,   2184

Shatterproof Glass Corp. v. Libbey-Owens Ford Co., 758 F.2d 613, 225 USPQ 634 (Fed. Cir. 1985) 2133.03(b)

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3793 Ex Parte Placek et al 13589956 - (D) SONG 103 WILSON, SONSINI, GOODRICH & ROSATI MEHL, PATRICK M

3711 Ex Parte May et al 14159524 - (D) STAICOVICI 103 THE BLK LAW GROUP GRAHAM, MARKS

3763 Ex Parte Kuang et al 14358105 - (D) SHAH 102/103 Cantor Colburn LLP - Carrier LING, FORK

3782 Ex Parte Bäck et al 13994970 - (D) SAINDON 103 SCA Hygiene Products AB c/o Buchanan Ingersoll & Rooney, PC PHILIPS, BRADLEY H

3793 Ex Parte KAKU et al 13934419 - (D) COTTA 112(2)/103 BIRCH, STEW ART, KOLASCH & BIRCH, LLP HOFFMAN, JOANNE M

3794 Ex Parte Willyard et al 13043665 - (D) HORNER 103 Covidien LP HUPCZEY, JR, RONALD JAMES

AFFIRMED-IN-PART
Tech Center 2100 Computer Architecture and Software
2139 Ex Parte TATI et al 13760868 - (D) POTHIER 103 103 Patterson & Sheridan, LLP - VMware KNIGHT, PAUL M

Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2822 Ex Parte Hecht et al 13827253 - (D) CASHION 112(2)/103 103 MURPHY, BILAK & HOMILLER/INFINEON TECHNOLOGIES NGUYEN, SOPHIA T

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3668 Ex Parte ROCKWELL et al 14282015 - (D) FITZPATRICK 101/103 103 BROOKS KUSHMAN P.C./FG1L INGRAM, THOMAS P

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3793 Ex Parte Grudem et al 14176256 - (D) PLENZLER 112(2)/103 112(1) Covidien LP PEHLKE, CAROLYN A

AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1616 Ex Parte Blizzard 14115276 - (D) FREDMAN 103 Ballard Spahr LLP KARPINSKI, LUKE E

1619 Ex Parte Lindell et al 12619851 - (D) MILLS 103 BAKER & HOSTETLER LLP THAKOR, DEV ANG K

1619 Ex Parte Lindell et al 13871476 - (D) MILLS 103 BAKER & HOSTETLER LLP THAKOR, DEV ANG K

Tech Center 1700 Chemical & Materials Engineering
1723 Ex Parte Kim et al 14008815 - (D) HOUSEL 103 Foley & Lardner LLP DIGNAN, MICHAEL L

1787 Ex Parte Sakata 13702885 - (D) REN 103 KNOBBE MARTENS OLSON & BEAR LLP CHEN, VNIAN

1788 Ex Parte He et al 13839978 - (D) HASTINGS 103 MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP GOLDEN, CHINESSA T

1794 Ex Parte Vinton et al 13823084 - (D) McGEE 112(1)/103 Squire Patton Boggs (PAL Office) CHUNG, HO-SUNG

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2443 Ex Parte Lelkens et al 13319769 - (D) SHIANG 103 PHILIPS LIGHTING HOLDING B.V. MURRAY, DANIEL C

Tech Center 2600 Communications
2627 Ex Parte Abrahams et al 14953107 - (D) CRAIG 103 Cuenot, Forsythe & Kim, LLC SUBEDI, DEEPROSE D

2646 Ex Parte CUOMO et al 14563107 - (D) BELISLE 103/OTDP Cantor Colburn LLP - IBM Endicott KINCAID, LESTER G

2646 Ex Parte CUOMO et al 14817415 - (D) BELISLE 103/OTDP Cantor Colburn LLP - IBM Endicott KINCAID, LESTER G

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3626 Ex Parte Quigley et al 13799724 - (D) WIEDER 101 Mattingly & Malur, PC - Square SEREBOFF, NEAL

3643 Ex Parte Whitcomb 14681339 - (D) HOELTER Dissenting-in-Part PLENZLER 112(2)/102/103 Jeffrey L. Streets PARSLEY, DAVID J

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3772 Ex Parte Cinader et al 14007033 - (D) ADAMS 103 3M INNOVATIVE PROPERTIES COMPANY MORAN, EDWARD JOHN

wesslau, burroughs, coleman, hybritech, sewall, skoner

custom search

REVERSED
Tech Center 1600 Biotechnology and Organic Chemistry
1619 Ex Parte Qiu et al 10891407 - (D) WALSH 103 CIBA VISION CORPORATION ALAWADI, SARAH

“It is impermissible within the framework of section 103 to pick and choose from any one reference only so much of it as will support a given position, to the exclusion of other parts necessary to the full appreciation of what such reference fairly suggests to one of ordinary skill in the art.” In re Wesslau, 353 F.2d 238, 241 (CCPA 1965).

1621 Ex Parte JOHNSEN et al 12621551 - (D) SNEDDEN 112(2)/103/obviousnesstype double patenting 37 CFR § 41.50(b) obviousnesstype double patenting GE HEALTHCARE, INC. PUTTLITZ, KARL J

1621 Ex Parte HOMESTAD 12621571 - (D) SNEDDEN 112(2)/103/obviousnesstype double patenting 37 CFR § 41.50(b) obviousnesstype double patenting GE HEALTHCARE, INC. PUTTLITZ, KARL J

1621 Ex Parte JOHNSEN et al 12621556 - (D) SNEDDEN 112(2)/102/103/obviousness-type double patenting 37 CFR § 41.50(b) obviousness-type double patenting GE HEALTHCARE, INC. PUTTLITZ, KARL J

Tech Center 1700 Chemical & Materials Engineering
1789 Ex Parte Grube et al 11755452 - (D) BEST 103 GAF WILLIAM J. DAVIS, ESQ. JOHNSON, JENNA LEIGH

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3643 Ex Parte Zine 12368494 - (D) WALSH 103 Bay Area Technolgy Law Group PC PARSLEY, DAVID J

AFFIRMED-IN-PART
Tech Center 1600 Biotechnology and Organic Chemistry
1629 Ex Parte Habash et al 11815440 - (D) WALSH 112(1)/103 102/103 37 CFR § 41.50(b) 102 KNOBBE MARTENS OLSON & BEAR LLP TOWNSLEY, SARA ELIZABETH

Tech Center 3900 Central Reexamination Unit (CRU)
2186 NVIDIA CORPORATION Respondent v. RAMBUS, INC. Patent Owner, Appellant 95001189 7287119 11/681,384 SIU 103 102/103 STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C. CHOI, WOO H original BATAILLE, PIERRE MICHE

3504 NVIDIA CORPORATION Respondent v. RAMBUS, INC. Patent Owner, Appellant 95001205 7360050 SIU 103 102/103 STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C. CHOI, WOO H original SAFAVI, MICHAEL

AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1628 Ex Parte Leonard 11757764 - (D) FREDMAN 103 MYERS BIGEL SIBLEY & SAJOVEC BADIO, BARBARA P

See In re Skoner, 517 F.2d 947, 950 (CCPA 1975) (“Expected beneficial results are evidence of obviousness of a claimed invention. Just as unexpected beneficial results are evidence of unobviousness.”)

1647 Ex Parte Champion et al 11188417 - (D) FREDMAN 103/obviousness-type double patenting FROMMER LAWRENCE & HAUG BUNNER, BRIDGET E

Tech Center 1700 Chemical & Materials Engineering
1712 Ex Parte Meiere 11063638 - (D) GAUDETTE 103/obviousness-type double patenting PRAXAIR, INC. HORNING, JOEL G

1777 Ex Parte Arpaia et al 10556803 - (D) DELMENDO 103 OBLON, SPIVAK, MCCLELLAND MAIER & NEUSTADT, L.L.P. XU, XIAOYUN

1792 Ex Parte Barnett et al 11669580 - (D) KRATZ 103 CARSTENS & CAHOON, LLP WILLIAMS, LELA

Tech Center 2100 Computer Architecture and Software
2181 Ex Parte Battaglia et al 10994271 - (D) MCKONE 103 OBLON, SPIVAK, MCCLELLAND MAIER & NEUSTADT, L.L.P. LEWIS-TAYLOR, DAYTON A.

2181 Ex Parte Sakiyama et al 10775080 - (D) THOMAS 103 BUCHANAN, INGERSOLL & ROONEY PC LEE, CHUN KUAN

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2447 Ex Parte Olchanski et al 09996475 - (D) THOMAS 103 WILMERHALE/DC TANG, KAREN C

For starters, we focus on the issue of conception. As comprehensively set forth by the Federal Circuit in Burroughs Wellcome Co. v. Barr Labs., Inc., 40 F.3d 1223, 1227-28 (Fed. Cir. 1994):

Conception is the touchstone of inventorship, the completion of the mental part of invention. Sewall v. Walters, 21 F.3d 411, 415, 30 USPQ2d 1356, 1359 (Fed. Cir. 1994). It is “the formation in the mind of the inventor, of a definite and permanent idea of the complete and operative invention, as it is hereafter to be applied in practice.” Hybritech Inc. v. Monoclonal Antibodies, Inc., 802 F.2d 1367, 1376, 231 USPQ 81, 87 (Fed. Cir. 1986) (citation omitted). Conception is complete only when the idea is so clearly defined in the inventor's mind that only ordinary skill would be necessary to reduce the invention to practice, without extensive research or experimentation. Sewall, 21 F.3d at 415, 30 USPQ2d at 1359; see also Coleman v. Dines, 754 F.2d 353, 359, 224 USPQ 857, 862 (Fed. Cir. 1985) (conception must include every feature of claimed invention). Because it is a mental act, courts require corroborating evidence of a contemporaneous disclosure that would enable one skilled in the art to make the invention. Coleman v. Dines, 754 F.2d at 359, 224 USPQ at 862.

Burroughs Wellcome Co. v. Barr Labs., Inc., 40 F.3d 1223, 32 USPQ2d 1915 (Fed. Cir. 1994) 2138.04, 2163

Hybritech, Inc. v. Monoclonal Antibodies, Inc., 802 F.2d 1367, 231 USPQ 81 (Fed. Cir. 1986) 716.03(b), 2138.04, 2145, 2163, 2164.01, 2164.05(a), 2173.05(a), 2182, 2184

Coleman v. Dines, 754 F.2d 353, 224 USPQ 857 (Fed. Cir. 1985) 2138.04

Tech Center 2600 Communications
2646 Ex Parte Kirke 11422638 - (D) CURCURI 103 GARLICK & MARKISON OBAYANJU, OMONIYI

2682 Ex Parte McEwan 10419274 - (D) CALDWELL 103 NIXON PEABODY, LLP NGUYEN, NAM V

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3623 Ex Parte Smith et al 10899656 - (D) TURNER 103 WILLIAM L. PARADICE, III ANDERSON, FOLASHADE

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3788 Ex Parte Clough 11961936 - (D) OSINSKI 112(2)/103 DORITY & MANNING, P.A. FIDEI, DAVID  

Tech Center 3900 Central Reexamination Unit (CRU)
2783 Ex parte MOTOROLA MOBILITY, INC. Patent Owner & Appellant 90010889 5958006 08/574,541 BLANKENSHIP 103 OBLON, SPIVAK, MCCLELLAND MAIER & NEUSTADT, L.L.P. RYMAN, DANIEL J original COLEMAN, ERIC